Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

HRS 2017: EBR's Leadless CRT Feasibility; Watchman Registry Data; A Novel AF Ablation Catheter From BW; And More Medtronic CRT Data

Executive Summary

Results from "real-world" registries of established devices, along with encouraging early results from novel devices were among the highlights of Heart Rhythm 2017, the annual scientific sessions of the Heart Rhythm Society, held in Chicago May 10-13.

Advertisement

Related Content

HRS 2017: Medtronic And Boston Scientific's Less-Invasive CRM Devices Perform As Hoped In Real-World Registries
St. Jude Pauses LEADLESS II Trial Of Nanostim Following Reports Of Lost Telemetry
ESC Roundup: Questions Raised About Remote Monitoring Benefits And Preventative ICDs; Medtronic Upgrades CRT Algorithms
Valves, Neurovascular, Diabetes Highlight Medtronic’s Fiscal 2016 Performance
Boston Sci's Watchman Gets Positive Medicare Coverage Policy
J&J Enters LAA Closure Market In Earnest With Coherex Buy
APPROVALS ANALYSIS: Diagnostics, Cardiovascular Devices Lead Big Month

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT104864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel